Navigating the Latest Policy Trends Shaping Product Commercialization
AMCP Webinar hosted by FormularyDecisions®
FormularyDecisions® provides US healthcare decisionmakers with access to evidence-based resources and bi-directional communication with life sciences manufacturers. If you are a healthcare decision maker and would like to have complimentary access to FormularyDecisions®, click here to register.
In today's rapidly changing healthcare landscape, staying informed on the latest health policy trends is crucial for effectively engaging with stakeholders and decision-makers. Our upcoming live webinar is a must-attend event and will delve into three critical topics that are currently shaping the industry: the Inflation Reduction Act (IRA), health equity, and Pre-approval Information Exchange (PIE). You'll discover how the IRA is set to impact drug pricing and spending, including the timeline for implementation and the potential effects on biopharma companies. You'll also learn about the strides being made to improve access to care for medically underserved patients through the implementation of health equity considerations. Lastly, we'll explore how the PIE Act is transforming the way that biopharma companies and healthcare decision-makers exchange information, and the opportunities this presents in the digital era. Don't miss the chance to hear from AmerisourceBergen thought leaders, who will share their unique insights and help you stay ahead of the curve.
Objectives:
- Summarize the knowns and unknowns of the Inflation Reduction Act (IRA) and its potential impacts on the biopharma industry.
- Discuss common challenges and gaps in health equity considerations and how stakeholders can overcome these barriers.
- Discuss the role of the Pre-approval Information Exchange (PIE) Act of 2022 on product commercialization planning and identify methods through which healthcare technology can be utilized.
Panelists:
- Corey Ford
Vice President, Reimbursement & Policy Insights
AmerisourceBergen/Xcenda - Patricia Doykos
Executive Director, Health Equity, Corporate Affairs
Bristol-Myers Squibb - Nancy Young
Vice President, Commercialization Services
AmerisourceBergen
Moderator:
- Tasmina Hydery
Associate Director, Digital Solutions
AmerisourceBergen/Xcenda
